(Q36648327)

15 August 2017

1 reference

title

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment (English)

1 reference

X-linked adrenoleukodystrophy

15 August 2017

0 references

1 reference

2

Ronald J A Wanders

1 reference

15 August 2017

Stephan Kemp

1

1 reference

15 August 2017

publication date

7 November 2006

1 reference

Molecular Genetics and Metabolism

15 August 2017

published in

1 reference

15 August 2017

volume

90

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

268-276

1 reference

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Fatty acid abnormality in adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Peroxisomes, lipid metabolism, and peroxisomal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Characterization and functional analysis of the nucleotide binding fold in human peroxisomal ATP binding cassette transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Adrenoleukodystrophy: the restoration of peroxisomal beta-oxidation by transfection of normal cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Primary structure of human PMP69, a putative peroxisomal ABC-transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Identification of a fourth half ABC transporter in the human peroxisomal membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

A multidrug resistance transporter from human MCF-7 breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Role of ABCG2/BCRP in biology and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Transport of activated fatty acids by the peroxisomal ATP-binding-cassette transporter Pxa2 in a semi-intact yeast cell system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

X-linked adrenoleukodystrophy: genes, mutations, and phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Phenotypic heterogeneity of sitosterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Proteins and enzymes of the peroxisomal membrane in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Fenofibrate differently alters expression of genes encoding ATP-binding transporter proteins of the peroxisomal membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Visualization and quantitation of peroxisomes using fluorescent nanocrystals: treatment of rats and monkeys with fibrates and detection in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Genomic organization of the 70-kDa peroxisomal membrane protein gene (PXMP1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

PEX11alpha is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

PEX11 promotes peroxisome division independently of peroxisome metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Histone deacetylases (HDACs): characterization of the classical HDAC family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Biochemical effect of intravenous arginine butyrate in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2006.10.001

1 reference

15 August 2017

1 reference